71 related articles for article (PubMed ID: 21597713)
1. Oncoprotein fos activation in epithelial-cells induces an epitheliomesenchymal conversion and changes the receptor encoded by the fgfr-2 messenger-RNA from k-sam to bek.
Scotet E; Reichmann E; Breathnach R; Houssaint E
Oncol Rep; 1995 Mar; 2(2):203-7. PubMed ID: 21597713
[TBL] [Abstract][Full Text] [Related]
2. Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences.
Le Guiner C; Plet A; Galiana D; Gesnel MC; Del Gatto-Konczak F; Breathnach R
J Biol Chem; 2001 Nov; 276(47):43677-87. PubMed ID: 11557769
[TBL] [Abstract][Full Text] [Related]
3. Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA.
Gilbert E; Del Gatto F; Champion-Arnaud P; Gesnel MC; Breathnach R
Mol Cell Biol; 1993 Sep; 13(9):5461-8. PubMed ID: 8355693
[TBL] [Abstract][Full Text] [Related]
4. Expression of FGFR2 BEK and K-SAM mRNA variants in normal and malignant human breast.
Luqmani YA; Bansal GS; Mortimer C; Buluwela L; Coombes RC
Eur J Cancer; 1996 Mar; 32A(3):518-24. PubMed ID: 8814701
[TBL] [Abstract][Full Text] [Related]
5. Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor.
Champion-Arnaud P; Ronsin C; Gilbert E; Gesnel MC; Houssaint E; Breathnach R
Oncogene; 1991 Jun; 6(6):979-87. PubMed ID: 1648704
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.
Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M
Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin.
Mansukhani A; Dell'Era P; Moscatelli D; Kornbluth S; Hanafusa H; Basilico C
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3305-9. PubMed ID: 1373495
[TBL] [Abstract][Full Text] [Related]
8. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion.
Reichmann E; Schwarz H; Deiner EM; Leitner I; Eilers M; Berger J; Busslinger M; Beug H
Cell; 1992 Dec; 71(7):1103-16. PubMed ID: 1473147
[TBL] [Abstract][Full Text] [Related]
9. The exon sequence TAGG can inhibit splicing.
Del Gatto F; Gesnel MC; Breathnach R
Nucleic Acids Res; 1996 Jun; 24(11):2017-21. PubMed ID: 8668531
[TBL] [Abstract][Full Text] [Related]
10. Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2.
Scotet E; Houssaint E
Oncogene; 1998 Jul; 17(1):67-76. PubMed ID: 9671315
[TBL] [Abstract][Full Text] [Related]
11. Cooperative binding of TIA-1 and U1 snRNP in K-SAM exon splicing activation.
Gesnel MC; Theoleyre S; Del Gatto-Konczak F; Breathnach R
Biochem Biophys Res Commun; 2007 Jul; 358(4):1065-70. PubMed ID: 17512901
[TBL] [Abstract][Full Text] [Related]
12. Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2).
Orr-Urtreger A; Bedford MT; Burakova T; Arman E; Zimmer Y; Yayon A; Givol D; Lonai P
Dev Biol; 1993 Aug; 158(2):475-86. PubMed ID: 8393815
[TBL] [Abstract][Full Text] [Related]
13. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity.
Itoh H; Hattori Y; Sakamoto H; Ishii H; Kishi T; Sasaki H; Yoshida T; Koono M; Sugimura T; Terada M
Cancer Res; 1994 Jun; 54(12):3237-41. PubMed ID: 8205545
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of K-sam protein in stomach cancer.
Hattori Y; Itoh H; Uchino S; Hosokawa K; Ochiai A; Ino Y; Ishii H; Sakamoto H; Yamaguchi N; Yanagihara K; Hirohashi S; Sugimura T; Terada M
Clin Cancer Res; 1996 Aug; 2(8):1373-81. PubMed ID: 9816310
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells.
Liu JJ; Shay JW; Wilson SE
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2584-93. PubMed ID: 9856768
[TBL] [Abstract][Full Text] [Related]
16. Isolation of the complementary DNA encoding a mouse heparin-binding growth factor receptor with the use of a unique kinase insert sequence.
Katoh O; Hattori Y; Sasaki H; Sakamoto H; Fujimoto K; Fujii T; Sugimura T; Terada M
Cancer Res; 1993 Mar; 53(5):1136-41. PubMed ID: 8382556
[TBL] [Abstract][Full Text] [Related]
17. Expression of fibroblast growth factor receptors flg and bek during hepatic ontogenesis and regeneration in the rat.
Hu Z; Evarts RP; Fujio K; Marsden ER; Thorgeirsson SS
Cell Growth Differ; 1995 Aug; 6(8):1019-25. PubMed ID: 8547216
[TBL] [Abstract][Full Text] [Related]
18. Re-programming of expression of the KGFR and bek variants of fibroblast growth factor receptor 2 during limb regeneration in newts (Notophthalmus viridescens).
Poulin ML; Chiu IM
Dev Dyn; 1995 Apr; 202(4):378-87. PubMed ID: 7626794
[TBL] [Abstract][Full Text] [Related]
19. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
20. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.
Miki T; Bottaro DP; Fleming TP; Smith CL; Burgess WH; Chan AM; Aaronson SA
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):246-50. PubMed ID: 1309608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
